The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 130:67-72, January 1973
doi: 10.1176/appi.ajp.130.1.67
© 1973 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by POST, R. M.
* Articles by GORDON, E. K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by POST, R. M.
* Articles by GORDON, E. K.

Psychomotor Activity and Cerebrospinal Fluid Amine Metabolites in Affective Illness

ROBERT M. POST M.D., JOEL KOTIN M.D.1, FREDERICK K. GOODWIN M.D., , and EDNA K. GORDON

1 Assistant Adjunct Professor of Psychiatry and Human Behavior, University of California at Irvine, Calif.

In order to evaluate the effect of psychomotor activity on CSF amine metabolites, lumbar punctures were performed after moderately depressed patients had simulated manic hyperactivity for four hours. The CSF levels of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were significantly higher after simulated mania or exercise alone than in the same patients after bed rest. In addition, there was a trend for levels of 3-methoxy-4-hydroxyphenylglycol to increase with activity. The levels of 5-HIAA and HVA correlated with the amount of motor activity: lowest in depression, intermediate in mania and hypomania, and highest in simulated mania. Both metabolites were higher in severe mania than in hypomania. These results suggest that psychomotor activity is an important determinant of CSF amine metabolite levels in affective illness.




This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
J. A. Pasco, L. J. Williams, F. N. Jacka, F. Ng, M. J. Henry, G. C. Nicholson, M. A. Kotowicz, and M. Berk
Tobacco smoking as a risk factor for major depressive disorder: population-based study
The British Journal of Psychiatry, October 1, 2008; 193(4): 322 - 326.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. H. Meyer, H. E. McNeely, S. Sagrati, A. Boovariwala, K. Martin, N. P. L.G. Verhoeff, A. A. Wilson, and S. Houle
Elevated Putamen D2 Receptor Binding Potential in Major Depression With Motor Retardation: An [11C]Raclopride Positron Emission Tomography Study
Am J Psychiatry, September 1, 2006; 163(9): 1594 - 1602.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
B. P. Taylor, G. E. Bruder, J. W. Stewart, P. J. McGrath, J. Halperin, H. Ehrlichman, and F. M. Quitkin
Psychomotor Slowing as a Predictor of Fluoxetine Nonresponse in Depressed Outpatients
Am J Psychiatry, January 1, 2006; 163(1): 73 - 78.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. Broocks, B. Bandelow, G. Pekrun, A. George, T. Meyer, U. Bartmann, U. Hillmer-Vogel, and E. Rüther
Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder
Am J Psychiatry, May 1, 1998; 155(5): 603 - 609.
[Abstract] [Full Text]


Home page
CLIN PEDIATRHome page
F. X. Castellanos
Toward a Pathophysiology of Attention-Deficit/Hyperactivint Disorder
Clinical Pediatrics, July 1, 1997; 36(7): 381 - 393.
[Abstract] [PDF]


Home page
ScienceHome page
S. Koslow and I. Butler
Biogenic amine synthesis defect in dihydropteridine reductase deficiency
Science, November 4, 1977; 198(4316): 522 - 523.
[Abstract] [PDF]


Home page
ScienceHome page
R. M. Post, E. K. Gordon, F. K. Goodwin, and W. E. Bunney Jr.
Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid
Science, March 9, 1973; 179(4077): 1002 - 1003.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1973 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org